Cargando…
Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches
Protein tyrosine phosphatase 1B (PTP1B) is a validated therapeutic target for Type 2 diabetes due to its specific role as a negative regulator of insulin signaling pathways. Discovery of active site directed PTP1B inhibitors is very challenging due to highly conserved nature of the active site and m...
Autores principales: | Shinde, Ranajit Nivrutti, Kumar, G. Siva, Eqbal, Shahbaz, Sobhia, M. Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005499/ https://www.ncbi.nlm.nih.gov/pubmed/29912965 http://dx.doi.org/10.1371/journal.pone.0199020 |
Ejemplares similares
-
In silico identification of novel PKC βII inhibitors: ligand and receptor based pharmacophore modeling, virtual screening, and molecular dynamics study
por: Grewal, Baljinder K, et al.
Publicado: (2012) -
Targeting the disordered C-terminus of PTP1B with an allosteric inhibitor
por: Krishnan, Navasona, et al.
Publicado: (2014) -
Molecular dynamics studies unravel role of conserved residues responsible for movement of ions into active site of DHBPS
por: Shinde, Ranajit Nivrutti, et al.
Publicado: (2017) -
Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor
por: McQueeney, Kelley E., et al.
Publicado: (2017) -
In silico study on identification of novel MALT1 allosteric inhibitors
por: Zhang, Jinrui, et al.
Publicado: (2019)